Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome

NCT06676033 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

5

Enrollment

NIH

Sponsor class

Conditions

Leukemia, Chronic Lymphocytic
Richter Syndrome

Interventions

DRUG: epcoritamab

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)